The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.
Study Type
OBSERVATIONAL
Enrollment
1,300
Patients hospitalized for SARS-COV2 infection
CHU de NICE - Infectiologie
Nice, France
RECRUITINGCHU de NICE - Urgences
Nice, France
RECRUITINGClinical characteristics
Describe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Time frame: 34 months
Biological characteristics
Describe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Time frame: 34 months
Radiological characteristics
Describe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Time frame: 34 months
Number of patient hospitalised for Covid-19
Inpatient up to Day 28 or discharge
Time frame: 34 months
Overall Inpatient Mortality
Number of death due to Covid-19
Time frame: 34 months
Requirement for mechanical ventilation
Number of patients requiring mechanical ventilation
Time frame: 34 months
ICU Length of Stay (LOS)
Duration measured in days
Time frame: 34 months
Evolution of patient general state during hospitalisation
the different measures (Body Mass Index (BMI), respiratory rate at rest, peripheral oxygen saturation, need for oxygen supplementation, body temperature) will be aggregated in order to obtain a clinical status corresponding to the clinical evolution (good or bad) of the patient's general state.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 34 months
Biological tests
Dosage of Lymphocytes, C-reactive protein and IL-6
Time frame: 34 months